Exodus Point Capital Management, LP Intellia Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $11.4 Billion
  • Q2 2025

A detailed history of Exodus Point Capital Management, LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 58,609 shares of NTLA stock, worth $636,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,609
Previous 87,652 33.13%
Holding current value
$636,493
Previous $623,000 11.72%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$6.28 - $9.67 $182,390 - $280,845
-29,043 Reduced 33.13%
58,609 $550,000
Q1 2025

May 14, 2025
SELL
$7.11 - $12.8 $129,224 - $232,640
-18,175 Reduced 17.17%
87,652 $623,000
Q4 2024

Feb 12, 2025
BUY
$11.41 - $21.09 $598,865 - $1.11 Million
52,486 Added 98.4%
105,827 $1.23 Million
Q3 2024

Nov 12, 2024
BUY
$19.72 - $27.36 $1.05 Million - $1.46 Million
53,341 New
53,341 $1.1 Million
Q1 2024

May 14, 2024
BUY
$23.82 - $32.8 $1.17 Million - $1.62 Million
49,316 Added 156.88%
80,752 $2.22 Million
Q3 2023

Nov 09, 2023
BUY
$31.62 - $45.78 $764,508 - $1.11 Million
24,178 Added 333.12%
31,436 $994,000
Q2 2023

Aug 10, 2023
BUY
$34.58 - $46.03 $250,981 - $334,085
7,258 New
7,258 $296,000
Q4 2022

Feb 13, 2023
SELL
$33.21 - $62.69 $239,244 - $451,618
-7,204 Reduced 41.92%
9,982 $348,000
Q3 2022

Nov 10, 2022
BUY
$53.92 - $71.7 $500,539 - $665,591
9,283 Added 117.46%
17,186 $962,000
Q2 2022

Aug 19, 2022
SELL
$38.49 - $76.21 $359,496 - $711,801
-9,340 Reduced 54.17%
7,903 $409,000
Q1 2022

May 13, 2022
BUY
$58.27 - $118.99 $1 Million - $2.05 Million
17,243 New
17,243 $1.25 Million
Q4 2021

Feb 11, 2022
SELL
$100.76 - $138.36 $349,334 - $479,694
-3,467 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$132.37 - $176.78 $458,926 - $612,896
3,467 New
3,467 $465,000
Q1 2021

May 17, 2021
SELL
$46.59 - $83.68 $425,553 - $764,333
-9,134 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$18.83 - $63.53 $858,440 - $2.9 Million
-45,589 Reduced 83.31%
9,134 $497,000
Q3 2020

Nov 16, 2020
BUY
$17.47 - $24.93 $276,742 - $394,916
15,841 Added 40.74%
54,723 $1.09 Million
Q2 2020

Aug 14, 2020
BUY
$11.14 - $22.87 $433,145 - $889,231
38,882 New
38,882 $817,000
Q4 2019

Feb 14, 2020
SELL
$10.43 - $17.67 $136,518 - $231,282
-13,089 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$13.07 - $18.51 $171,073 - $242,277
13,089 New
13,089 $175,000

Others Institutions Holding NTLA

# of Institutions
341
Shares Held
95.7M
Call Options Held
1.29M
Put Options Held
1.09M
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $825M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email